Cravath’s London Office Moves to 100 Cheapside
Practice Area Attorney, Executive Compensation and Benefits
Deals & Cases
June 30, 2025
Cravath represented the initial purchasers in connection with the $650 million 144A/Reg. S high‑yield senior notes offering of Compass Minerals International, Inc., a leading provider of essential minerals. The transaction closed on June 16, 2025.
Deals & Cases
June 23, 2025
On June 23, 2025, Illumina, Inc. (“Illumina”) announced it has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data‑driven proteomics technology, and other specified assets for $350 million in cash payable at closing, subject to customary adjustments, plus up to $75 million in near-term performance‑based milestones and performance‑based royalties. Cravath is representing Illumina in connection with the transaction.
Deals & Cases
April 24, 2025
Cravath represented the borrower, FactSet Research Systems Inc., in connection with the arrangement of $1.5 billion of credit facilities used to refinance existing indebtedness and for working capital and other general corporate purposes. The facilities consisted of a $1 billion revolving credit facility and a $500 million term loan facility. The transactions closed on April 8, 2025.
Deals & Cases
April 15, 2025
Cravath represented AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust in connection with its $500 million registered fixed‑rate reset junior subordinated notes offering. AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust are wholly owned subsidiaries of AerCap Holdings N.V., the global leader in aircraft leasing. The notes will be listed on the Irish Stock Exchange. The transaction closed on April 1, 2025.
Deals & Cases
March 17, 2025
On March 17, 2025, PepsiCo, Inc. (“PepsiCo”) announced that it has entered into a definitive agreement to acquire poppi, a prebiotic soda brand, for $1.95 billion, including $300 million of anticipated cash tax benefits for a net purchase price of $1.65 billion. The transaction also includes an additional potential earnout consideration subject to the achievement of certain performance milestones within a specified period after closing of the transaction. Cravath is representing PepsiCo in connection with the transaction.
Deals & Cases
June 30, 2025
Cravath represented the initial purchasers in connection with the $650 million 144A/Reg. S high‑yield senior notes offering of Compass Minerals International, Inc., a leading provider of essential minerals. The transaction closed on June 16, 2025.
Deals & Cases
June 23, 2025
On June 23, 2025, Illumina, Inc. (“Illumina”) announced it has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data‑driven proteomics technology, and other specified assets for $350 million in cash payable at closing, subject to customary adjustments, plus up to $75 million in near-term performance‑based milestones and performance‑based royalties. Cravath is representing Illumina in connection with the transaction.
Deals & Cases
April 24, 2025
Cravath represented the borrower, FactSet Research Systems Inc., in connection with the arrangement of $1.5 billion of credit facilities used to refinance existing indebtedness and for working capital and other general corporate purposes. The facilities consisted of a $1 billion revolving credit facility and a $500 million term loan facility. The transactions closed on April 8, 2025.
Deals & Cases
April 15, 2025
Cravath represented AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust in connection with its $500 million registered fixed‑rate reset junior subordinated notes offering. AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust are wholly owned subsidiaries of AerCap Holdings N.V., the global leader in aircraft leasing. The notes will be listed on the Irish Stock Exchange. The transaction closed on April 1, 2025.
Deals & Cases
March 17, 2025
On March 17, 2025, PepsiCo, Inc. (“PepsiCo”) announced that it has entered into a definitive agreement to acquire poppi, a prebiotic soda brand, for $1.95 billion, including $300 million of anticipated cash tax benefits for a net purchase price of $1.65 billion. The transaction also includes an additional potential earnout consideration subject to the achievement of certain performance milestones within a specified period after closing of the transaction. Cravath is representing PepsiCo in connection with the transaction.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.